{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T10:50:31Z","timestamp":1781607031708,"version":"3.54.5"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,2]],"date-time":"2027-04-02T00:00:00Z","timestamp":1806624000000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD112007"],"award-info":[{"award-number":["R01HD112007"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD101450"],"award-info":[{"award-number":["R01HD101450"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00241580"],"award-info":[{"award-number":["RS-2023-00241580"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA234006"],"award-info":[{"award-number":["R37CA234006"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA237569"],"award-info":[{"award-number":["R01CA237569"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114870","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T17:14:31Z","timestamp":1774545271000},"page":"114870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Endogenous targeting lipid nanoparticles for systemic mRNA delivery to lung cancer tumors"],"prefix":"10.1016","volume":"394","author":[{"given":"Yoon Tae","family":"Goo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Grigoriev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetiana","family":"Korzun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongbrailatpam Shitaljit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissa","family":"Kioussi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena R.","family":"Taratula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel L.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleh","family":"Taratula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114870_bb0005","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","article-title":"The dawn of mRNA vaccines: the COVID-19 case","volume":"333","author":"Verbeke","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114870_bb0010","doi-asserted-by":"crossref","first-page":"8392","DOI":"10.1021\/acsnano.3c13039","article-title":"Antiangiogenic therapeutic mRNA delivery using lung-selective polymeric nanomedicine for lung cancer treatment","volume":"18","author":"Le","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114870_bb0015","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41568-023-00586-2","article-title":"mRNA-based cancer therapeutics","volume":"23","author":"Liu","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303261","article-title":"Lipid nanoparticle (LNP) enables mRNA delivery for cancer therapy","volume":"35","author":"Zong","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114870_bb0025","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1021\/acsnano.4c18636","article-title":"Ionizable lipids with optimized linkers enable lung-specific, lipid nanoparticle-mediated mRNA delivery for treatment of metastatic lung Tumors","volume":"19","author":"Somu Naidu","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114870_bb0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3390\/pharmaceutics15020622","article-title":"mRNA-based therapeutics in cancer treatment","volume":"15","author":"Sun","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114870_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12943-021-01348-0","article-title":"mRNA therapeutics in cancer immunotherapy","volume":"20","author":"Beck","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0040","article-title":"Nanoparticle-based Follistatin messenger RNA therapy for reprogramming metastatic ovarian Cancer and ameliorating Cancer-associated Cachexia","volume":"18","author":"Korzun","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114870_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-021-01329-3","article-title":"mRNA in cancer immunotherapy: beyond a source of antigen","volume":"20","author":"Van Hoecke","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0050","doi-asserted-by":"crossref","first-page":"33330","DOI":"10.1021\/acsnano.4c06930","article-title":"Targeting metastasis in head and neck squamous cell carcinoma using Follistatin mRNA lipid nanoparticles","volume":"18","author":"Grigoriev","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114870_bb0055","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticles from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114870_bb0060","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0065","article-title":"Development of mRNA lipid nanoparticles: targeting and therapeutic aspects","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114870_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102375","article-title":"Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia","volume":"35","author":"Soto","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.jconrel.2026.114870_bb0075","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.ymthe.2025.03.018","article-title":"CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery","volume":"33","author":"Papp","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.114870_bb0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/acschembio.0c00003","article-title":"Engineering caveolae-targeted lipid nanoparticles to deliver mRNA to the lungs","volume":"15","author":"Li","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0085","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.nanolett.4c05186","article-title":"Peptide-functionalized lipid nanoparticles for targeted systemic mRNA delivery to the brain","volume":"25","author":"Han","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114870_bb0090","article-title":"Esterase-labile quaternium lipidoid enabling improved mRNA-LNP stability and spleen-selective mRNA transfection","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114870_bb0095","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","article-title":"Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing","volume":"15","author":"Cheng","year":"2020","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0100","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109256118","article-title":"On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles","volume":"118","author":"Dilliard","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2026.114870_bb0105","doi-asserted-by":"crossref","DOI":"10.4028\/b-fVvR5S","article-title":"Design of PD-L1-targeted lipid nanoparticles to turn on PTEN for efficient Cancer therapy","volume":"11","author":"Kim","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114870_bb0110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307801120","article-title":"Cationic cholesterol-dependent LNP delivery to lung stem cells, the liver, and heart","volume":"121","author":"Radmand","year":"2024","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2026.114870_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202409812","article-title":"Simplified lipid nanoparticles for tissue-and cell-targeted mRNA delivery facilitate precision tumor therapy in a lung metastasis mouse model","volume":"36","author":"Fei","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114870_bb0120","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/s41467-024-45422-9","article-title":"High-throughput barcoding of nanoparticles identifies cationic, degradable lipid-like materials for mRNA delivery to the lungs in female preclinical models","volume":"15","author":"Xue","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114870_bb0125","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2023.07.058","article-title":"The interplay of quaternary ammonium lipid structure and protein corona on lung-specific mRNA delivery by selective organ targeting (SORT) nanoparticles","volume":"361","author":"Dilliard","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114870_bb0130","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.7150\/thno.86466","article-title":"Application of lung-targeted lipid nanoparticle-delivered mRNA of soluble PD-L1 via SORT technology in acute respiratory distress syndrome","volume":"13","author":"Sun","year":"2023","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114870_bb0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","article-title":"Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery","volume":"18","author":"Wang","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jconrel.2026.114870_bb0140","doi-asserted-by":"crossref","first-page":"7322","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114870_bb0145","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114870_bb0150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2116271119","article-title":"Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis","volume":"119","author":"Qiu","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2026.114870_bb0155","first-page":"L217","article-title":"Vascular expression of the \u03b1v\u03b23-integrin in lung and other organs","volume":"278","author":"Singh","year":"2000","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2026.114870_bb0160","first-page":"712","article-title":"Integrins \u03b1v\u03b23 and \u03b1v\u03b25 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide","volume":"60","author":"Erdreich-Epstein","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114870_bb0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/s42003-021-02003-6","article-title":"\u03b1v\u03b23 Integrin induces partial EMT independent of TGF-\u03b2 signaling","volume":"4","author":"Kariya","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0170","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3892\/mmr.2014.2860","article-title":"Integrin \u03b1v promotes proliferation by activating ERK 1\/2 in the human lung cancer cell line A549","volume":"11","author":"Fu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.jconrel.2026.114870_bb0175","article-title":"Lipid nanoparticle-mediated lymph node\u2013targeting delivery of mRNA cancer vaccine elicits robust CD8+ T cell response","volume":"119","author":"Chen","year":"2022","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2026.114870_bb0180","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1124\/jpet.113.211169","article-title":"Follistatin: a novel therapeutic for the improvement of muscle regeneration","volume":"349","author":"Yaden","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.114870_bb0185","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.7150\/thno.27847","article-title":"Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA","volume":"8","author":"Schumann","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114870_bb0190","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1158\/0008-5472.CAN-13-2702","article-title":"Activin upregulation by NF-\u03baB is required to maintain mesenchymal features of cancer stem\u2013like cells in non\u2013small cell lung cancer","volume":"75","author":"Wamsley","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114870_bb0195","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.lungcan.2021.09.008","article-title":"Clinical relevance of circulating activin a and follistatin in small cell lung cancer","volume":"161","author":"Barany","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0200","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1593\/neo.81582","article-title":"Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma","volume":"11","author":"Seder","year":"2009","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2026.114870_bb0205","doi-asserted-by":"crossref","first-page":"15007","DOI":"10.1038\/npjbcancer.2015.7","article-title":"Activin-a signaling promotes epithelial\u2013mesenchymal transition, invasion, and metastatic growth of breast cancer","volume":"1","author":"Bashir","year":"2015","journal-title":"NPJ Breast Cancer."},{"key":"10.1016\/j.jconrel.2026.114870_bb0210","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3390\/cancers7010070","article-title":"Intertwining of activin A and TGF\u03b2 signaling: dual roles in cancer progression and cancer cell invasion","volume":"7","author":"Loomans","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.114870_bb0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1158\/1541-7786.50.3.1","article-title":"Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells","volume":"3","author":"Steller","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114870_bb0220","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/or.2022.8318","article-title":"Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer","volume":"47","author":"Daitoku","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2026.114870_bb0225","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat3504","article-title":"Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy","volume":"10","author":"Marini","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114870_bb0230","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/14728222.2020.1799350","article-title":"Activin A: an emerging target for improving cancer treatment?","volume":"24","author":"Ries","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jconrel.2026.114870_bb0235","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1016\/j.clnu.2024.05.025","article-title":"Cancer cachexia as a predictor of adverse outcomes in patients with non-small cell lung cancer: a meta-analysis","volume":"43","author":"Zhang","year":"2024","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.jconrel.2026.114870_bb0240","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1667\/RR2565.1","article-title":"A novel bioluminescence orthotopic mouse model for advanced lung cancer","volume":"176","author":"Li","year":"2011","journal-title":"Radiat. Res."},{"key":"10.1016\/j.jconrel.2026.114870_bb0245","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12885-021-08205-9","article-title":"Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment","volume":"21","author":"Jarry","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020401118","article-title":"Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3","volume":"118","author":"Qiu","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2026.114870_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202303370","article-title":"Induction of bleb structures in lipid nanoparticle formulations of mRNA leads to improved transfection potency","volume":"35","author":"Cheng","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114870_bb0260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0265","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2023.06.014","article-title":"The role of protein corona on nanodrugs for organ-targeting and its prospects of application","volume":"360","author":"Wang","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114870_bb0270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jconrel.2024.07.044","article-title":"Biofluid specific protein coronas affect lipid nanoparticle behavior in vitro","volume":"373","author":"van Straten","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114870_bb0275","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41563-025-02331-6","article-title":"Peptide codes for organ-selective mRNA delivery","volume":"25","author":"Chang","year":"2026","journal-title":"Nat. Mater."},{"key":"10.1016\/j.jconrel.2026.114870_bb0280","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/pathogens13090800","article-title":"HIV modulates osteoblast differentiation via upregulation of RANKL and vitronectin","volume":"13","author":"Freiberger","year":"2024","journal-title":"Pathog"},{"key":"10.1016\/j.jconrel.2026.114870_bb0285","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3390\/molecules27061943","article-title":"Modification of lipid-based nanoparticles: an efficient delivery system for nucleic acid-based immunotherapy","volume":"27","author":"Zhang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2026.114870_bb0290","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1039\/D4NA00404C","article-title":"Synthesis and bioactivity of a novel surfactin-based lipopeptide for mRNA delivery","volume":"6","author":"Alqahtani","year":"2024","journal-title":"Nanoscale Adv."},{"key":"10.1016\/j.jconrel.2026.114870_bb0295","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/D4PM00128A","article-title":"Tailoring lipid nanoparticle dimensions through manufacturing processes","volume":"1","author":"McMillan","year":"2024","journal-title":"RSC Pharm."},{"key":"10.1016\/j.jconrel.2026.114870_bb0300","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0305","series-title":"LipidLaunch\u2122 LNP apparent pKa assay kit (TNS method)","year":"2026"},{"key":"10.1016\/j.jconrel.2026.114870_bb0310","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1357-2725(99)00005-9","article-title":"Vitronectin","volume":"31","author":"Schvartz","year":"1999","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0315","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/prot.1096","article-title":"Model for the three-dimensional structure of vitronectin: predictions for the multi-domain protein from threading and docking","volume":"44","author":"Xu","year":"2001","journal-title":"Proteins"},{"key":"10.1016\/j.jconrel.2026.114870_bb0320","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.micinf.2004.05.004","article-title":"Role of \u03b1v\u03b25 integrins and vitronectin in Pseudomonas aeruginosa PAK interaction with A549 respiratory cells","volume":"6","author":"Leroy-Dudal","year":"2004","journal-title":"Microbes Infect."},{"key":"10.1016\/j.jconrel.2026.114870_bb0325","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/MPA.0b013e318279d568","article-title":"The differentiation of pancreatic tumor-initiating cells by vitronectin can be blocked by cilengitide","volume":"42","author":"Cabarcas","year":"2013","journal-title":"Pancreas"},{"key":"10.1016\/j.jconrel.2026.114870_bb0330","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/annonc\/mdm140","article-title":"Assessment of the biological and pharmacological effects of the \u03b1\u03bd\u03b23 and \u03b1\u03bd\u03b25 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors","volume":"18","author":"Hariharan","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0335","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7150\/thno.4218","article-title":"Role of urokinase receptor in tumor progression and development","volume":"3","author":"Noh","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114870_bb0340","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s12885-019-5693-2","article-title":"Vitronectin as a molecular player of the tumor microenvironment in neuroblastoma","volume":"19","author":"Burgos-Panadero","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0242141","article-title":"Functional role of vitronectin in breast cancer","volume":"15","author":"Bera","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114870_bb0350","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s12885-016-2621-6","article-title":"The fibronectin III-1 domain activates a PI3-Kinase\/Akt signaling pathway leading to \u03b1v\u03b25 integrin activation and TRAIL resistance in human lung cancer cells","volume":"16","author":"Cho","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0355","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12967-018-1474-y","article-title":"The positive role of vitronectin in radiation induced lung toxicity: the in vitro and in vivo mechanism study","volume":"16","author":"Shen","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114870_bb0360","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/ijc.28267","article-title":"\u03b1v-Integrin isoform expression in primary human tumors and brain metastases","volume":"133","author":"Vogetseder","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0365","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/jclinpath-2013-202163","article-title":"Overexpression of integrin \u03b1v correlates with poor prognosis in colorectal cancer","volume":"67","author":"Ha","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0370","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hep.1840200606","article-title":"Distribution of vitronectin in plasma and liver tissue: relationship to chronic liver disease","volume":"20","author":"Kobayashi","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2026.114870_bb0375","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ijrobp.2010.01.038","article-title":"Plasma proteomic analysis may identify new markers for radiation-induced lung toxicity in patients with non\u2013small-cell lung cancer","volume":"77","author":"Cai","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2026.114870_bb0380","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/JTO.0b013e3182152ba6","article-title":"Baseline plasma proteomic analysis to identify biomarkers that predict radiation-induced lung toxicity in patients receiving radiation for non-small cell lung cancer","volume":"6","author":"Cai","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0385","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2021.01.018","article-title":"The plasma levels and polymorphisms of vitronectin predict radiation pneumonitis in patients with lung cancer receiving thoracic radiation therapy","volume":"110","author":"Yu","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jconrel.2026.114870_bb0390","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223840","article-title":"Identification of protein changes in the blood plasma of lung cancer patients subjected to chemotherapy using a 2D-DIGE approach","volume":"14","author":"Ciereszko","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114870_bb0395","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1021\/nn500136z","article-title":"Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm","volume":"8","author":"Howard","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114870_bb0400","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1124\/jpet.300.3.777","article-title":"Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature","volume":"300","author":"Scherpereel","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2026.114870_bb0405","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1164\/rccm.200809-1522ST","article-title":"An official research policy statement of the American Thoracic Society\/European Respiratory Society: standards for quantitative assessment of lung structure","volume":"181","author":"Hsia","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2026.114870_bb0410","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1164\/rccm.200308-1107OC","article-title":"The number of alveoli in the human lung","volume":"169","author":"Ochs","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2026.114870_bb0415","first-page":"L405","article-title":"A retrospective of lung morphometry: from 1963 to present","author":"Weibel","year":"2013","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.jconrel.2026.114870_bb0420","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/sj.bjc.6600015","article-title":"Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas","volume":"86","author":"Passalidou","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114870_bb0425","first-page":"1417","article-title":"Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis","volume":"151","author":"Pezzella","year":"1997","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0430","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41467-022-35701-8","article-title":"In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma","volume":"14","author":"Taniguchi","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114870_bb0435","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2017.01.011","article-title":"Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling","volume":"391","author":"Dean","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114870_bb0440","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1359\/jbmr.090219","article-title":"Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer","volume":"24","author":"Kang","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.jconrel.2026.114870_bb0445","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3892\/or.2023.8688","article-title":"Activin A induces apoptosis of human lung adenocarcinoma A549 cells through endoplasmic reticulum stress pathway","volume":"51","author":"Zhang","year":"2024","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2026.114870_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068597","article-title":"NF-\u03baB regulates mesenchymal transition for the induction of non-small cell lung cancer initiating cells","volume":"8","author":"Kumar","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2026.114870_bb0455","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/me.2010-0127","article-title":"Regulation of muscle mass by follistatin and activins","volume":"24","author":"Lee","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0460","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/s41388-019-1103-0","article-title":"A NF-\u0138B-Activin A signaling axis enhances prostate cancer metastasis","volume":"39","author":"Chen","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2026.114870_bb0465","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1002\/art.22953","article-title":"Activin A is an anticatabolic autocrine cytokine in articular cartilage whose production is controlled by fibroblast growth factor 2 and NF-\u03baB","volume":"56","author":"Alexander","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2026.114870_bb0470","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.7150\/thno.51976","article-title":"Metallothionein-1G suppresses pancreatic cancer cell stemness by limiting activin A secretion via NF-\u03baB inhibition","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114870_bb0475","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neo.2020.12.006","article-title":"Tumor necrosis factor in lung cancer: complex roles in biology and resistance to treatment","volume":"23","author":"Gong","year":"2021","journal-title":"Neoplasia"},{"key":"10.1016\/j.jconrel.2026.114870_bb0480","first-page":"295","article-title":"Significance of expression of TGF-b in pulmonary metastasis in non-small cell lung cancer tissues","volume":"9","author":"Saji","year":"2003","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.jconrel.2026.114870_bb0485","doi-asserted-by":"crossref","first-page":"24842","DOI":"10.1021\/acsnano.4c05088","article-title":"Lipid nanoparticles elicit reactogenicity and sickness behavior in mice via toll-like receptor 4 and myeloid differentiation protein 88 axis","volume":"18","author":"Korzun","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114870_bb0490","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"Reed","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2026.114870_bb0495","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.biocel.2013.04.023","article-title":"Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome","volume":"45","author":"Sandri","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114870_bb0500","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/aps.2012.194","article-title":"Coordination of autophagy with other cellular activities","volume":"34","author":"Wang","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.jconrel.2026.114870_bb0505","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1242\/bio.2012364","article-title":"Matched rabbit monoclonal antibodies against \u03b1v-series integrins reveal a novel \u03b1v\u03b23-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors","volume":"1","author":"Goodman","year":"2012","journal-title":"Biol. Open"},{"key":"10.1016\/j.jconrel.2026.114870_bb0510","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7796","article-title":"High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma","volume":"7","author":"Hoda","year":"2016","journal-title":"Oncotarget"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926002725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:00:40Z","timestamp":1779757240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926002725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":102,"alternative-id":["S0168365926002725"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114870","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endogenous targeting lipid nanoparticles for systemic mRNA delivery to lung cancer tumors","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114870"}}